Here’s the report

“The Polish Pharmaceutical Chamber estimated that 300,000 patients could be eligible under the regime, which includes chronic pain, drug-resistant epilepsy, multiple sclerosis symptoms, and chemotherapy-induced nausea.

“Given the fact that there are nearly 15,000 pharmacies in Poland, an overwhelming majority is authorized to make prescription drugs – that’s around 90 percent,” a spokesperson for the Polish Pharmaceutical Chamber said in the report, adding that courses will be available to professionals who may require additional training.”

Poland MMJ Law Takes Effect; Products to be Sold in Pharmacies